San Francisco Bay Area biotech stories.
Monday, May 21, 2012
Takeda closing South San Francisco antibody research site
Drug maker Takeda will close the South San Francisco site it once tagged as a key
to developing early-stage antibody drugs.
The Japanese company said it is consolidating its South San Francisco and San Diego operations, now called Takeda California, in San Diego.
The move comes as Asia's largest drug maker deals with a falling stock price and declining sales of its best-selling drug, the diabetes treatment Actos, even as net income climbed,
according to the news agency Bloomberg
. It had
announced the consolidation in December
but held off until Friday on disclosing the fate of the Bay Area site.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)